act lung injury ali affect patient hospitals critic care respiratory distress syndrome ard sever form mortal rate region slow increment progress identify biomass contribute pathophysiolog until diagnosis monitor potent therapeutic target cafe c delucchi k person pe thompson bt ware lb matthew lancet redir med howe major issue heterogen multifactori endstag conduit strategy lump split prescott hc ang dc liu vx j crit nevertheless sequence human genome avail improv method analysis transcript mra gene express develop density immunoassay allow applied network biology offer personal precise medicine sweeney te khaki p toward biomass panel applied molecular phenotype identify risk develop static two subphenotyp identify base blood hypoinflammatori hyperinflammatori subphenotyp assoc shock metal acids worst clinic outcome particular interest include interleukin il interferon gamma inγ surface protein spd spb von willebrand factor antigen angiopoietin plasminogen active inhibitor pai term found increase neutrophilrel gene sepsisinduc influenzainduc whole give robust diagnose test despite improv manga unit complex disease continue lifethreaten event trial βagonist station surface keratinocyt growth kg disappoint admit monoclonal antibody antitnf tnr fusion protein also unconvinced advance meghan until neuromuscular blocker cisatracurium basil shown benefit stem cell therapy develop future understand role hope provide ration ultima improv seymour cw gomez h chang ch vermont g kelly ja kennedy end 